recombinant SARS-CoV-2 vaccine (Ad5 vector)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for recombinant SARS-CoV-2 vaccine (Ad5 vector), covering 2022-03-31 to 2022-03-31. Get the full timeline:
Most recent: Clinical Trial Update: Study on Sequential Immunization of Inactivated SARS-CoV-2 Vaccine and Recombinant SARS-CoV-2 Vaccine (Ad5 Vector) [Phase 4]